Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
It is a proatherogenic substance that is associated with risks of cardiovascular disease
The brand's FAQ content states that side effects depend on the specific therapy, and mentions mild GI upset, headache, or injection-site reactions as possibilities for some options
The authors declare that they have no competing interests
Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease
Summary measures and synthesis of results The principal summary outcome was the relative risk (RR) of several GI adverse events in people with overweight or obesity receiving treatment with GLP-1 RA, including nausea, vomiting, diarrhea, constipation, abdominal distension, upper abdominal pain, abdominal pain, abdominal discomfort, gastroesophageal reflux disease, (GERD), eructation, flatulence, decreased appetite, cholelithiasis, gallstone-related, cholecystitis, acute cholecystitis, acute pancreatitis, viral gastroenteritis, hard feces, and infrequent bowel movements
The eyecare practitioner should communicate the small possible risk of NAION, while acknowledging that a causal association with GLP-1 drugs has not been established, to other members of the care team to better inform prescribing decisions
US$ 27.04
US$ 26.83
US$ 20.74
